Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration

Favipiravir as a potential countermeasure against neglected and emerging RNA viruses

(2018) Leen Delang et al.   ANTIVIRAL RESEARCH

Second International Conference on Crimean-Congo Hemorrhagic Fever

(2018) Jessica R. Spengler et al.   ANTIVIRAL RESEARCH

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

(2017) Yousuke FURUTA et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir

(2017) Jonna B. Westover et al.   VIROLOGY

Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014

(2016) Chang-Qing Bai et al.   CLINICAL INFECTIOUS DISEASES

Characterization of Glycoprotein-Mediated Entry of Severe Fever with Thrombocytopenia Syndrome Virus

(2016) Hideki Tani et al.   JOURNAL OF VIROLOGY

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

(2016) Daouda Sissoko et al.   PLOS MEDICINE

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus

(2016) Hideki Tani et al.   mSphere

Ebola virus (EBOV) infection: Therapeutic strategies

(2015) Erik De Clercq   BIOCHEMICAL PHARMACOLOGY

Severe fever with thrombocytopenia syndrome and its pathogen SFTSV

(2015) Xiao-Ying Lei et al.   MICROBES AND INFECTION

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

(2014) Lisa Oestereich et al.   ANTIVIRAL RESEARCH

Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

(2014) Sophie J. Smither et al.   ANTIVIRAL RESEARCH

Effects of Ribavirin on Severe Fever with Thrombocytopenia Syndrome Virus In Vitro

(2014) Masayuki Shimojima et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Sensitive and Specific PCR Systems for Detection of Both Chinese and Japanese Severe Fever with Thrombocytopenia Syndrome Virus Strains and Prediction of Patient Survival Based on Viral Load

(2014) Tomoki Yoshikawa et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis

(2014) Quan Liu et al.   LANCET INFECTIOUS DISEASES

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever

(2014) Lisa Oestereich et al.   PLoS Neglected Tropical Diseases

Case-Fatality Ratio and Effectiveness of Ribavirin Therapy Among Hospitalized Patients in China Who Had Severe Fever With Thrombocytopenia Syndrome

(2013) Wei Liu et al.   CLINICAL INFECTIOUS DISEASES

The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan

(2013) Toru Takahashi et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Features and Factors Associated with Severity and Fatality among Patients with Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection in Northeast China

(2013) Baocheng Deng et al.   PLoS One

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever

(2013) Brian B. Gowen et al.   PLoS Neglected Tropical Diseases

Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome Patients

(2012) Z.-T. Gai et al.   JOURNAL OF INFECTIOUS DISEASES